We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2010 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01152593
First Posted: June 29, 2010
Last Update Posted: June 29, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Hillel Yaffe Medical Center
May 31, 2010
June 29, 2010
June 29, 2010
July 2010
July 2014   (Final data collection date for primary outcome measure)
Reduction of the incidence of surgical site infections after cesarean section [ Time Frame: Four years ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections
Not Provided
The investigators believe that irradication of nose colonization of staphyloccocus aureus will reduce the incidence of surgical site infections after cesarean section.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
  • Surgical Wound Infection
  • Cesarean Section
  • Staphylococcus Aureus
Drug: Mupirocin
Intranasal cream given to patient after confirmation of colonization
Experimental: Intranasal Mupirocin
Intervention: Drug: Mupirocin
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
400
December 2014
July 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Women assigned to undergo cesarean section

Exclusion Criteria:

  • All others
Sexes Eligible for Study: Female
Child, Adult, Senior
Not Provided
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT01152593
HYMC0033-10
Not Provided
Not Provided
Not Provided
Gai Shrem, MD, Hillel Yaffe Medical Center
Hillel Yaffe Medical Center
Not Provided
Not Provided
Hillel Yaffe Medical Center
June 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP